Innovating Works

LINDEN COMANSA

Activa
PnuBioVax: PnuBioVax next generation vaccine for a personalised and effective immune response against Strepto... IMMUNOBIOLOGY LIMITED tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Pneumococcal disease, caused by the pathogenic bacteria Streptococcus pneumoniae, is a major cause of mortality in the young and elderly. In...
2019-05-11 - 2019-09-30 | Financiado
TIL-FIT: Increasing the fitness of tumor infiltrating T cells for cellular immunotherapy FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un H2020: ERC-2018-STG Adoptive T cell therapies (ACTs) are emerging as a promising strategy to treat cancer. Tumor-infiltrating lymphocytes (TILs) are expanded ex...
2018-12-12 - 2023-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.